Article
Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
29 Mar 2018
Abstract excerpt
Background: Although canonical Wnt signaling is known to promote tumorigenesis in pancreatic ductal adenocarcinoma (PDAC), a cancer driven principally by mutant K-Ras, the detailed molecular mechanisms by which the Wnt effector β-catenin regulates such tumorigenesis are largely unknown. We have previously demonstrated that β-catenin’s differential usage of the Kat3 transcriptional coactivator cyclic AMP-response...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
